当前位置：
X-MOL 学术
›
Crit. Rev. Oncol. Hematol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Corrigendum to "Cetuximab in locally advanced head and neck squamous cell carcinoma: Biological mechanisms involved in efficacy, toxicity and resistance" [Crit. Rev. Oncol./Hematol. 164 (2021) 1-11/103424].
Critical Reviews in Oncology/Hematology ( IF 6.2 ) Pub Date : 2021-09-17 , DOI: 10.1016/j.critrevonc.2021.103479 Elena Muraro 1 , Giuseppe Fanetti 2 , Valentina Lupato 3 , Vittorio Giacomarra 3 , Agostino Steffan 1 , Carlo Gobitti 2 , Emanuela Vaccher 4 , Giovanni Franchin 2
中文翻译：
“西妥昔单抗治疗局部晚期头颈部鳞状细胞癌：疗效、毒性和耐药性的生物学机制”更正 [Crit. Rev. Oncol./Hematol。164 (2021) 1-11/103424]。
更新日期：2021-09-17
Critical Reviews in Oncology/Hematology ( IF 6.2 ) Pub Date : 2021-09-17 , DOI: 10.1016/j.critrevonc.2021.103479 Elena Muraro 1 , Giuseppe Fanetti 2 , Valentina Lupato 3 , Vittorio Giacomarra 3 , Agostino Steffan 1 , Carlo Gobitti 2 , Emanuela Vaccher 4 , Giovanni Franchin 2
Affiliation
中文翻译：
“西妥昔单抗治疗局部晚期头颈部鳞状细胞癌：疗效、毒性和耐药性的生物学机制”更正 [Crit. Rev. Oncol./Hematol。164 (2021) 1-11/103424]。
京公网安备 11010802027423号